{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T21:28:25Z","timestamp":1770067705010,"version":"3.49.0"},"publisher-location":"Dordrecht","reference-count":53,"publisher":"Springer Netherlands","isbn-type":[{"value":"9789402409406","type":"print"},{"value":"9789402409420","type":"electronic"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1007\/978-94-024-0942-0_12","type":"book-chapter","created":{"date-parts":[[2016,10,13]],"date-time":"2016-10-13T13:05:38Z","timestamp":1476363938000},"page":"211-221","source":"Crossref","is-referenced-by-count":8,"title":["Treatment of Hepatitis E"],"prefix":"10.1007","author":[{"given":"Wei","family":"Hui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linlin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuo","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinhui","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,10,14]]},"reference":[{"issue":"1","key":"12_CR1","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/cid\/ciu742","volume":"60","author":"F Abravanel","year":"2015","unstructured":"Abravanel F, Lhomme S, Rostaing L, Kamar N, Izopet J (2015) Protracted fecal shedding of HEV during ribavirin therapy predicts treatment relapse. Clinical Infect Dis 60(1):96\u201399","journal-title":"Clinical Infect Dis"},{"issue":"1","key":"12_CR2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-0029-1192052","volume":"29","author":"R Adam","year":"2009","unstructured":"Adam R, Hoti E (2009) Liver transplantation: the current situation. Semin Liver Dis 29(1):3\u201318","journal-title":"Semin Liver Dis"},{"issue":"6","key":"12_CR3","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1002\/hep.24674","volume":"54","author":"R Aggarwal","year":"2011","unstructured":"Aggarwal R, Jameel S (2011) Hepatitis E. Hepatology 54(6):2218\u20132226","journal-title":"Hepatology"},{"key":"12_CR4","doi-asserted-by":"crossref","first-page":"872431","DOI":"10.1155\/2015\/872431","volume":"2015","author":"A Ahmed","year":"2015","unstructured":"Ahmed A, Ali IA, Ghazal H, Fazili J, Nusrat S (2015) Mystery of hepatitis e virus: recent advances in its diagnosis and management. Int J Hepatol 2015:872431","journal-title":"Int J Hepatol"},{"issue":"5","key":"12_CR5","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.jhep.2016.01.011","volume":"64","author":"L Allweiss","year":"2016","unstructured":"Allweiss L, Gass S, Giersch K, Groth A, Kah J, Volz T, Rapp G, Sch\u00f6bel A, Lohse AW, Polywka S (2016) Human liver chimeric mice as a new model of chronic hepatitis E virus infection and preclinical drug evaluation. J Hepatol 64(5):1033\u20131040","journal-title":"J Hepatol"},{"issue":"3","key":"12_CR6","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1046\/j.1365-2893.1998.00096.x","volume":"5","author":"VA Arankalle","year":"1998","unstructured":"Arankalle VA, Chadha MS, Dama BM, Tsarev SA, Purcell RH, Banerjee K (1998) Role of immune serum globulins in pregnant women during an epidemic of hepatitis E. J Viral Hepat 5(3):199\u2013204","journal-title":"J Viral Hepat"},{"issue":"2","key":"12_CR7","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1572-0241.2006.00416.x","volume":"101","author":"TN Chau","year":"2006","unstructured":"Chau TN, Lai ST, Tse C, Ng TK, Leung VK, Lim W, Ng MH (2006) Epidemiology and clinical features of sporadic hepatitis E as compared with hepatitis A. Am J Gastroenterol 101(2):292\u2013296","journal-title":"Am J Gastroenterol"},{"issue":"35","key":"12_CR8","doi-asserted-by":"crossref","first-page":"5904","DOI":"10.3748\/wjg.v19.i35.5904","volume":"19","author":"SH Cheng","year":"2013","unstructured":"Cheng SH, Mai L, Zhu FQ, Pan XF, Sun HX, Cao H, Shu X, Ke WM, Li G, Xu QH (2013) Influence of chronic HBV infection on superimposed acute hepatitis E. World J Gastroenterol 19(35):5904\u20135909","journal-title":"World J Gastroenterol"},{"issue":"7","key":"12_CR9","doi-asserted-by":"crossref","first-page":"479","DOI":"10.7326\/0003-4819-155-7-201110040-00017","volume":"155","author":"HR Dalton","year":"2011","unstructured":"Dalton HR, Keane FE, Bendall R, Mathew J, Ijaz S (2011) Treatment of chronic hepatitis E in a patient with HIV infection. Ann Intern Med 155(7):479\u2013480","journal-title":"Ann Intern Med"},{"issue":"4","key":"12_CR10","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1159\/000444468","volume":"34","author":"HR Dalton","year":"2016","unstructured":"Dalton HR, Webb GW, Norton BC, Woolson KL (2016) Hepatitis E virus: time to change the textbooks. Dig Dis 34(4):308\u2013316","journal-title":"Dig Dis"},{"issue":"1","key":"12_CR11","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1053\/j.gastro.2015.09.011","volume":"150","author":"VL Dao Thi","year":"2016","unstructured":"Dao Thi VL, Debing Y, Wu X, Rice CM, Neyts J, Moradpour D, Gouttenoire J (2016) Sofosbuvir inhibits hepatitis E virus replication in vitro and results in an additive effect when combined with ribavirin. Gastroenterology 150(1):82\u201385 e84","journal-title":"Gastroenterology"},{"issue":"2","key":"12_CR12","doi-asserted-by":"crossref","first-page":"227","DOI":"10.7326\/0003-4819-106-2-227","volume":"106","author":"KM Cock De","year":"1987","unstructured":"De Cock KM, Bradley DW, Sandford NL, Govindarajan S, Maynard JE, Redeker AG (1987) Epidemic non-A, non-B hepatitis in patients from Pakistan. Ann Intern Med 106(2):227\u2013230","journal-title":"Ann Intern Med"},{"key":"12_CR13","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jcv.2016.05.006","volume":"80","author":"JD Debes","year":"2016","unstructured":"Debes JD, Pisano MB, Lotto M, Re V (2016) Hepatitis E virus infection in the HIV-positive patient. J Clin Virol 80:102\u2013106","journal-title":"J Clin Virol"},{"issue":"1","key":"12_CR14","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1128\/AAC.01795-13","volume":"58","author":"Y Debing","year":"2014","unstructured":"Debing Y, Emerson SU, Wang Y, Pan Q, Balzarini J, Dallmeier K, Neyts J (2014) Ribavirin inhibits in vitro hepatitis E virus replication through depletion of cellular GTP pools and is moderately synergistic with alpha interferon. Antimicrob Agents Chemother 58(1):267\u2013273","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"12_CR15","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.jhep.2012.05.010","volume":"57","author":"A Bello Del","year":"2012","unstructured":"Del Bello A, Arne-Bes MC, Lavayssiere L, Kamar N (2012) Hepatitis E virus-induced severe myositis. J Hepatol 57(5):1152\u20131153","journal-title":"J Hepatol"},{"key":"12_CR16","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3389\/fphys.2013.00351","volume":"4","author":"U Drebber","year":"2013","unstructured":"Drebber U, Odenthal M, Aberle SW, Winkel N, Wedemeyer I, Hemberger J, Holzmann H, Dienes HP (2013) Hepatitis E in liver biopsies from patients with acute hepatitis of clinically unexplained origin. Front Physiol 4:351","journal-title":"Front Physiol"},{"issue":"1","key":"12_CR17","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jcv.2011.06.004","volume":"52","author":"R Gerolami","year":"2011","unstructured":"Gerolami R, Borentain P, Raissouni F, Motte A, Solas C, Colson P (2011) Treatment of severe acute hepatitis E by ribavirin. J Clin Virol 52(1):60\u201362","journal-title":"J Clin Virol"},{"key":"12_CR18","doi-asserted-by":"publisher","unstructured":"Gouttenoire J, Szkolnicka D, Moradpour D (2016) Treatment of chronic hepatitis E with ribavirin: lessons from deep sequencing. Gut. doi: 10.1136\/gutjnl-2016-312040","DOI":"10.1136\/gutjnl-2016-312040"},{"issue":"6","key":"12_CR19","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.3851\/IMP2317","volume":"17","author":"R Goyal","year":"2012","unstructured":"Goyal R, Kumar A, Panda SK, Paul SB, Acharya SK (2012) Ribavirin therapy for hepatitis E virus-induced acute on chronic liver failure: a preliminary report. Antivir Ther 17(6):1091\u20131096","journal-title":"Antivir Ther"},{"issue":"4","key":"12_CR20","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/lt.22014","volume":"16","author":"EB Haagsma","year":"2010","unstructured":"Haagsma EB, Riezebos-Brilman A, van den Berg AP, Porte RJ, Niesters HG (2010) Treatment of chronic hepatitis E in liver transplant recipients with pegylated interferon alpha-2b. Liver Transplant 16(4):474\u2013477","journal-title":"Liver Transplant"},{"issue":"1","key":"12_CR21","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/BF02935040","volume":"4","author":"J He","year":"1998","unstructured":"He J, Wang C (1998) Treatment of severe cholestatic hepatitis by integrating traditional Chinese and Western medicines. Chin J Integr Tradit West Med 4(1):18\u201321","journal-title":"Chin J Integr Tradit West Med"},{"key":"12_CR22","doi-asserted-by":"publisher","unstructured":"Hillebrandt KH, Arsenic R, Hofmann J, Eurich D, Gul S, Strucker B, Sauer IM, Pratschke J, Stockmann M, Raschzok N (2016) Acute graft dysfunction 17 years after liver transplant: a challenging clinical and histologic manifestation of hepatitis E. Exp Clin Transplant. doi: 10.6002\/ect.2015.0343","DOI":"10.6002\/ect.2015.0343"},{"issue":"8","key":"12_CR23","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1093\/ndt\/gfq282","volume":"25","author":"N Kamar","year":"2010","unstructured":"Kamar N, Abravanel F, Garrouste C, Cardeau-Desangles I, Mansuy JM, Weclawiak H, Izopet J, Rostaing L (2010) Three-month pegylated interferon-alpha-2a therapy for chronic hepatitis E virus infection in a haemodialysis patient. Nephrol Dial Transplant 25(8):2792\u20132795","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"12_CR24","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/TP.0b013e3181c4096c","volume":"89","author":"N Kamar","year":"2010","unstructured":"Kamar N, Abravanel F, Selves J, Garrouste C, Esposito L, Lavayssiere L, Cointault O, Ribes D, Cardeau I, Nogier MB, Mansuy JM, Muscari F, Peron JM, Izopet J, Rostaing L (2010) Influence of immunosuppressive therapy on the natural history of genotype 3 hepatitis-E virus infection after organ transplantation. Transplantation 89(3):353\u2013360","journal-title":"Transplantation"},{"issue":"5","key":"12_CR25","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1086\/650488","volume":"50","author":"N Kamar","year":"2010","unstructured":"Kamar N, Rostaing L, Abravanel F, Garrouste C, Esposito L, Cardeau-Desangles I, Mansuy JM, Selves J, Peron JM, Otal P, Muscari F, Izopet J (2010) Pegylated interferon-alpha for treating chronic hepatitis E virus infection after liver transplantation. Clin Infect Dis 50(5):e30\u2013e33","journal-title":"Clin Infect Dis"},{"issue":"5","key":"12_CR26","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1053\/j.gastro.2010.08.002","volume":"139","author":"N Kamar","year":"2010","unstructured":"Kamar N, Rostaing L, Abravanel F, Garrouste C, Lhomme S, Esposito L, Basse G, Cointault O, Ribes D, Nogier MB, Alric L, Peron JM, Izopet J (2010) Ribavirin therapy inhibits viral replication on patients with chronic hepatitis e virus infection. Gastroenterology 139(5):1612\u20131618","journal-title":"Gastroenterology"},{"issue":"5","key":"12_CR27","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1053\/j.gastro.2011.02.050","volume":"140","author":"N Kamar","year":"2011","unstructured":"Kamar N, Garrouste C, Haagsma EB, Garrigue V, Pischke S, Chauvet C, Dumortier J, Cannesson A, Cassuto-Viguier E, Thervet E, Conti F, Lebray P, Dalton HR, Santella R, Kanaan N, Essig M, Mousson C, Radenne S, Roque-Afonso AM, Izopet J, Rostaing L (2011) Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology 140(5):1481\u20131489","journal-title":"Gastroenterology"},{"issue":"9835","key":"12_CR28","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/S0140-6736(11)61849-7","volume":"379","author":"N Kamar","year":"2012","unstructured":"Kamar N, Bendall R, Legrand-Abravanel F, Xia NS, Ijaz S, Izopet J, Dalton HR (2012) Hepatitis E. Lancet 379(9835):2477\u20132488","journal-title":"Lancet"},{"issue":"1","key":"12_CR29","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1128\/CMR.00057-13","volume":"27","author":"N Kamar","year":"2014","unstructured":"Kamar N, Dalton HR, Abravanel F, Izopet J (2014) Hepatitis E virus infection. Clin Microbiol Rev 27(1):116\u2013138","journal-title":"Clin Microbiol Rev"},{"issue":"12","key":"12_CR30","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1056\/NEJMoa1215246","volume":"370","author":"N Kamar","year":"2014","unstructured":"Kamar N, Izopet J, Tripon S, Bismuth M, Hillaire S, Dumortier J, Radenne S, Coilly A, Garrigue V, D\u2019Alteroche L, Buchler M, Couzi L, Lebray P, Dharancy S, Minello A, Hourmant M, Roque-Afonso AM, Abravanel F, Pol S, Rostaing L, Mallet V (2014) Ribavirin for chronic hepatitis E virus infection in transplant recipients. N Engl J Med 370(12):1111\u20131120","journal-title":"N Engl J Med"},{"issue":"1","key":"12_CR31","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.clinre.2014.07.005","volume":"39","author":"N Kamar","year":"2015","unstructured":"Kamar N, Abravanel F, Lhomme S, Rostaing L, Izopet J (2015) Hepatitis E virus: chronic infection, extra-hepatic manifestations, and treatment. Clin Res Hepatol Gastroenterol 39(1):20\u201327","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"10","key":"12_CR32","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1097\/TP.0000000000000850","volume":"99","author":"N Kamar","year":"2015","unstructured":"Kamar N, Lhomme S, Abravanel F, Cointault O, Esposito L, Cardeau-Desangles I, Del Bello A, Dorr G, Lavayssiere L, Nogier MB, Guitard J, Ribes D, Goin AL, Broue P, Metsu D, Saune K, Rostaing L, Izopet J (2015) An early viral response predicts the virological response to ribavirin in hepatitis E virus organ transplant patients. Transplantation 99(10):2124\u20132131","journal-title":"Transplantation"},{"issue":"9","key":"12_CR33","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1517\/14728222.2015.1056155","volume":"19","author":"SP Kenney","year":"2015","unstructured":"Kenney SP, Meng XJ (2015) Therapeutic targets for the treatment of hepatitis E virus infection. Expert Opin Ther Targets 19(9):1245\u20131260","journal-title":"Expert Opin Ther Targets"},{"issue":"2","key":"12_CR34","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.cld.2012.03.009","volume":"16","author":"V Khungar","year":"2012","unstructured":"Khungar V, Poordad F (2012) Hepatic encephalopathy. Clin Liver Dis 16(2):301\u2013320","journal-title":"Clin Liver Dis"},{"issue":"3","key":"12_CR35","first-page":"113","volume":"11","author":"MS Khuroo","year":"1992","unstructured":"Khuroo MS, Dar MY (1992) Hepatitis E: evidence for person-to-person transmission and inability of low dose immune serum globulin from an Indian source to prevent it. Indian J Gastroenterol 11(3):113\u2013116","journal-title":"Indian J Gastroenterol"},{"issue":"3","key":"12_CR36","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jceh.2013.08.013","volume":"3","author":"A Kumar","year":"2013","unstructured":"Kumar A, Saraswat VA (2013) Hepatitis E and Acute-on-Chronic Liver Failure. J Clin Exp Hepatol 3(3):225\u2013230","journal-title":"J Clin Exp Hepatol"},{"issue":"4","key":"12_CR37","doi-asserted-by":"crossref","first-page":"343","DOI":"10.5501\/wjv.v4.i4.343","volume":"4","author":"GY Lee","year":"2015","unstructured":"Lee GY, Poovorawan K, Intharasongkroh D, Sa-Nguanmoo P, Vongpunsawad S, Chirathaworn C, Poovorawan Y (2015) Hepatitis E virus infection: epidemiology and treatment implications. World J Virol 4(4):343\u2013355","journal-title":"World J Virol"},{"issue":"3","key":"12_CR38","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1128\/AAC.02496-15","volume":"60","author":"S Lhomme","year":"2016","unstructured":"Lhomme S, Kamar N, Nicot F, Ducos J, Bismuth M, Garrigue V, Petitjean-Lecherbonnier J, Ollivier I, Alessandri-Gradt E, Goria O, Barth H, Perrin P, Saune K, Dubois M, Carcenac R, Lefebvre C, Jeanne N, Abravanel F, Izopet J (2016) Mutation in the hepatitis E virus polymerase and outcome of ribavirin therapy. Antimicrob Agents Chemother 60(3):1608\u20131614","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"12_CR39","doi-asserted-by":"crossref","first-page":"85","DOI":"10.7326\/0003-4819-153-2-201007200-00257","volume":"153","author":"V Mallet","year":"2010","unstructured":"Mallet V, Nicand E, Sultanik P, Chakvetadze C, Tesse S, Thervet E, Mouthon L, Sogni P, Pol S (2010) Brief communication: case reports of ribavirin treatment for chronic hepatitis E. Ann Intern Med 153(2):85\u201389","journal-title":"Ann Intern Med"},{"issue":"5","key":"12_CR40","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1002\/hep.24622","volume":"54","author":"JC Olson","year":"2011","unstructured":"Olson JC, Wendon JA, Kramer DJ, Arroyo V, Jalan R, Garcia-Tsao G, Kamath PS (2011) Intensive care of the patient with cirrhosis. Hepatology 54(5):1864\u20131872","journal-title":"Hepatology"},{"key":"12_CR41","doi-asserted-by":"crossref","first-page":"789","DOI":"10.2217\/fmb-2016-0012","volume":"11","author":"MT Perez-Gracia","year":"2016","unstructured":"Perez-Gracia MT, Suay-Garcia B, Garcia M, Mateos-Lindemann ML (2016) Hepatitis E: latest developments in knowledge. Future Microbiol 11:789\u2013808","journal-title":"Future Microbiol"},{"issue":"6","key":"12_CR42","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.jhep.2011.01.009","volume":"54","author":"JM Peron","year":"2011","unstructured":"Peron JM, Dalton H, Izopet J, Kamar N (2011) Acute autochthonous hepatitis E in western patients with underlying chronic liver disease: a role for ribavirin? J Hepatol 54(6):1323\u20131324; author reply 1324\u20131325","journal-title":"J Hepatol"},{"issue":"12","key":"12_CR43","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/jvh.12403","volume":"22","author":"AM Peters van Ton","year":"2015","unstructured":"Peters van Ton AM, Gevers TJ, Drenth JP (2015) Antiviral therapy in chronic hepatitis E: a systematic review. J Viral Hepat 22(12):965\u2013973","journal-title":"J Viral Hepat"},{"issue":"5","key":"12_CR44","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/liv.12114","volume":"33","author":"S Pischke","year":"2013","unstructured":"Pischke S, Hardtke S, Bode U, Birkner S, Chatzikyrkou C, Kauffmann W, Bara CL, Gottlieb J, Wenzel J, Manns MP, Wedemeyer H (2013) Ribavirin treatment of acute and chronic hepatitis E: a single-centre experience. Liver Int 33(5):722\u2013726","journal-title":"Liver Int"},{"issue":"12","key":"12_CR45","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/lt.24213","volume":"21","author":"I Ramsay","year":"2015","unstructured":"Ramsay I, Snell L, Sharma V, O\u2019Beirne J, Patch D, Marshall A, Imber C, Ijaz S, Dianne I, Westbrook RH (2015) Liver transplantation for acute liver failure because of genotype 3 hepatitis E virus infection. Liver Transplant 21(12):1557\u20131559","journal-title":"Liver Transplant"},{"issue":"2","key":"12_CR46","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/MCG.0000000000000113","volume":"49","author":"M Riveiro-Barciela","year":"2015","unstructured":"Riveiro-Barciela M, Minguez B, Girones R, Rodriguez-Frias F, Quer J, Buti M (2015) Phylogenetic demonstration of hepatitis E infection transmitted by pork meat ingestion. J Clin Gastroenterol 49(2):165\u2013168","journal-title":"J Clin Gastroenterol"},{"issue":"19","key":"12_CR47","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1056\/NEJMoa010307","volume":"345","author":"E Rivers","year":"2001","unstructured":"Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M, Early Goal-Directed Therapy Collaborative, G (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345(19):1368\u20131377","journal-title":"N Engl J Med"},{"issue":"4","key":"12_CR48","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jcv.2014.05.003","volume":"60","author":"A Robbins","year":"2014","unstructured":"Robbins A, Lambert D, Ehrhard F, Brodard V, Hentzien M, Lebrun D, Nguyen Y, Tabary T, Peron JM, Izopet J, Bani-Sadr F (2014) Severe acute hepatitis E in an HIV infected patient: successful treatment with ribavirin. J Clin Virol 60(4):422\u2013423","journal-title":"J Clin Virol"},{"key":"12_CR49","doi-asserted-by":"crossref","first-page":"e26645","DOI":"10.5812\/jjm.26645","volume":"9","author":"S Shayanpour","year":"2016","unstructured":"Shayanpour S, Hayati F (2016) Hepatitis E virus infection among chronic hemodialysis. Jundishapur J Microbiol 9:e26645","journal-title":"Jundishapur J Microbiol"},{"issue":"5","key":"12_CR50","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/bjs.7418","volume":"98","author":"BM Stutchfield","year":"2011","unstructured":"Stutchfield BM, Simpson K, Wigmore SJ (2011) Systematic review and meta-analysis of survival following extracorporeal liver support. Br J Surg 98(5):623\u2013631","journal-title":"Br J Surg"},{"issue":"22","key":"12_CR51","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.3748\/wjg.v22.i22.5143","volume":"22","author":"R Taherkhani","year":"2016","unstructured":"Taherkhani R, Farshadpour F (2016) Epidemiology of hepatitis E virus in Iran. World J Gastroenterol 22(22):5143\u20135153","journal-title":"World J Gastroenterol"},{"issue":"12","key":"12_CR52","doi-asserted-by":"crossref","first-page":"285","DOI":"10.4254\/wjh.v3.i12.285","volume":"3","author":"EH Teshale","year":"2011","unstructured":"Teshale EH, Hu DJ (2011) Hepatitis E: epidemiology and prevention. World J Hepatol 3(12):285\u2013291","journal-title":"World J Hepatol"},{"issue":"1","key":"12_CR53","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1055\/s-0033-1338118","volume":"33","author":"H Wedemeyer","year":"2013","unstructured":"Wedemeyer H, Rybczynska J, Pischke S, Krawczynski K (2013) Immunopathogenesis of hepatitis E virus infection. Semin Liver Dis 33(1):71\u201378","journal-title":"Semin Liver Dis"}],"container-title":["Advances in Experimental Medicine and Biology","Hepatitis E Virus"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-94-024-0942-0_12","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T10:18:50Z","timestamp":1749637130000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-94-024-0942-0_12"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9789402409406","9789402409420"],"references-count":53,"URL":"https:\/\/doi.org\/10.1007\/978-94-024-0942-0_12","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}